Zhen-Mei An (Zhenmei An)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 6

Top Topics

Network Analysis

Low Density Lipoprotein

Top Venues

Disease markers

Diabetes therapy : research, treatment and education of diabetes and related disorders

BioMed research international

BMC endocrine disorders

This page only lists publications with an associated author ORCID identifier.

Publications

Yuping Zeng, He He, Zhen-Mei An
Advance of Serum Biomarkers and Combined Diagnostic Panels in Nonalcoholic Fatty Liver Disease. Disease markers 2022 (2022)
Shenling Liao, Kang An, Zhi Liu, He He, Zhen-Mei An, Qiaoli Su, Shuangqing Li
Genetic variants associated with metabolic dysfunction-associated fatty liver disease in western China. Journal of clinical laboratory analysis 36 (9) (2022)
Yu Zhang, He He, Yu-Ping Zeng, Li-Dan Yang, Dan Jia, Zhen-Mei An, Wei-Guo Jia
Lipoprotein A, combined with alanine aminotransferase and aspartate aminotransferase, contributes to predicting the occurrence of NASH: a cross-sectional study. Lipids in health and disease 19 (1) (2020)
Huiwen Tan, Dawei Chen, Yerong Yu, Kai Yu, Weiming He, Bowen Cai, Su Jiang, Ying Tang, Nanwei Tong, Zhen-Mei An
Unusual ectopic ACTH syndrome in a patient with orbital neuroendocrine tumor, resulted false-positive outcome of BIPSS:a case report. BMC endocrine disorders 20 (1) (2020)
Yuping Zeng, He He, Yu Zhang, Xia Wang, Lidan Yang, Zhen-Mei An
CCNB2, TOP2A, and ASPM Reflect the Prognosis of Hepatocellular Carcinoma, as Determined by Weighted Gene Coexpression Network Analysis. BioMed research international 2020 (2020)
Lidan Yang, Lin Zhang, He He, Mei Zhang, Zhen-Mei An
Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in East Asians with Type 2 Diabetes: A Systematic Review and Meta-Analysis. Diabetes therapy : research, treatment and education of diabetes and related disorders 10 (5) (2019)